ALXN - Alexion Pharmaceuticals Inc. (ALXN) CEO Ludwig Hantson on Q4 2018 Results - Earnings Call Transcript
Alexion Pharmaceuticals, Inc. (ALXN)
Q4 2018 Earnings Conference Call
February 04, 2019, 08:00 ET
Company Participants
Susan Altschuller - VP, IR
Ludwig Hantson - CEO & Director
Paul Clancy - EVP & CFO
John Orloff - EVP and Head, Research & Development
Brian Goff - EVP & Chief Commercial Officer
Conference Call Participants
Geoffrey Porges - Leerink
Terence Flynn - Goldman Sachs Group
Kennen MacKay - RBC Capital Markets
Geoffrey Meacham - Barclays Bank
Christopher Raymond - Piper Jaffray Companies
Paul Matteis - Stifel, Nicolaus & Company
Robyn Karnauskas - Citigroup
Ying Huang - Bank